Interestingly, in contrast to patients with FS, LGL leukemia/RA patients exhibited increased LGL counts >2 x 10e9/L (21% vs. 0% in FS) and STAT3 mutations (39% vs. 0% in FS) (28). This evidence concerns the gene STAT3 and rheumatoid arthritis.